Skip to main content
Log in

Left Atrial Strain Insights in Atrial Fibrillation and the Interplay with Metabolic Syndrome

  • Original Research
  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Introduction

Understanding the interplay between metabolic syndrome and left atrial (LA) function is crucial, especially in patients newly diagnosed with atrial fibrillation (AF). We evaluated the association between subclinical atrial function and metabolic syndrome in patients diagnosed with new-onset AF.

Methods

A retrospective analysis was conducted on 220 patients, aged between 20 and 100 years, who were newly diagnosed with AF. These patients were divided into two groups based on the presence or absence of metabolic syndrome. LA reservoir strain, a measure of LA function, was assessed using transthoracic echocardiography. Statistical methods, including receiver operating characteristic (ROC) curve and logistic regression analyses, were employed to evaluate the association between LA strain and metabolic syndrome.

Results

Among the 220 patients, 108 had metabolic syndrome and displayed more adverse clinical characteristics. The LA reservoir strain was significantly lower in this group (9.7% ± 5.2% vs. 12.0% ± 5.8%, p = 0.003). ROC curve analysis identified 9.3% as the optimal cutoff value for predicting metabolic syndrome, with a sensitivity of 50.9% and specificity of 70.5%. Further, multivariate analysis confirmed that an LA reservoir strain below 9.3% was independently linked to metabolic syndrome (odds ratio 4.261, 95% confidence interval 1.134–16.009, p = 0.032).

Conclusions

The findings reveal a significant association between lower LA reservoir strain values and the presence of metabolic syndrome in patients newly diagnosed with AF. An LA strain value below 9.3% serves as a critical diagnostic and prognostic indicator, highlighting its clinical importance in managing patients with AF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498.

    Article  PubMed  Google Scholar 

  2. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139:e56–528.

    Article  PubMed  Google Scholar 

  3. Walters TE, Wick K, Tan G, et al. Symptom severity and quality of life in patients with atrial fibrillation: psychological function outweighs clinical predictors. Int J Cardiol. 2019;279:84–9.

    Article  PubMed  Google Scholar 

  4. Huh JH, Kang DR, Kim JY, Koh KK. Metabolic syndrome fact sheet 2021: executive report. Cardiometab Syndr J. 2021;1:125–34.

    Article  Google Scholar 

  5. Oliver W, Matthews G, Ayers CR, et al. Factors associated with left atrial remodeling in the general population. Circ Cardiovasc Imaging. 2017;10:e005047.

  6. Malaescu GG, Mirea O, Capota R, et al. Left atrial strain determinants during the cardiac phases. JACC Cardiovasc Imaging. 2022;15:381–91.

    Article  PubMed  Google Scholar 

  7. Sun BJ, Park JH, Lee M, et al. Normal reference values for left atrial strain and its determinants from a large Korean multicenter registry. J Cardiovasc Imaging. 2020;28:186–98.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kim YG, Choi KJ, Han S, et al. Metabolic syndrome and the risk of new-onset atrial fibrillation in middle-aged East Asian men. Circ J. 2018;82:1763–9.

    Article  PubMed  Google Scholar 

  9. Kwon CH, Kim H, Kim SH, et al. The impact of metabolic syndrome on the incidence of atrial fibrillation: a nationwide longitudinal cohort study in South Korea. J Clin Med. 2019;8:1095.

  10. Yilmaz H, Ozcan KS, Sayar N, et al. Metabolic syndrome is associated with atrial electrical and mechanical dysfunction. Med Princ Pract. 2015;24:147–52.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735–52.

    Article  PubMed  Google Scholar 

  12. Hong AR, Lim S. Clinical characteristics of metabolic syndrome in Korea, and its comparison with other Asian countries. J Diabetes Investig. 2015;6:508–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Cameli M, Mandoli GE, Loiacono F, et al. Left atrial strain: a useful index in atrial fibrillation. Int J Cardiol. 2016;220:208–13.

    Article  PubMed  Google Scholar 

  14. Badano LP, Kolias TJ, Muraru D, et al. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2018;19:591–600.

    Article  PubMed  Google Scholar 

  15. Pathan F, D’Elia N, Nolan MT, Marwick TH, Negishi K. Normal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysis. J Am Soc Echocardiogr. 2017;30(59–70): e8.

    Google Scholar 

  16. Ionin V, Zaslavskaya E, Barashkova E, et al. Cardiotrophin-1 and components of metabolic syndrome: what is the role in the development of atrial fibrillation? EP Europace. 2021;23. https://doi.org/10.1093/europace/euab116.131.

  17. Ionin VA, Zaslavskaya EL, Barashkova EI, et al. Molecular mechanisms of left atrial fibrosis development in patients with atrial fibrillation and metabolic syndrome: what biomarkers should be used in clinical practice? Russian J Cardiol. 2021;26:4579.

  18. Biccire FG, Bucci T, Menichelli D, et al. Mediterranean diet: a tool to break the relationship of atrial fibrillation with the metabolic syndrome and non-alcoholic fatty liver disease. Nutrients. 2022;14:1260.

  19. Zheng Y, Xie Z, Li J, et al. Meta-analysis of metabolic syndrome and its individual components with risk of atrial fibrillation in different populations. BMC Cardiovasc Disord. 2021;21:90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Sabatino J, De Rosa S, Leo I, et al. Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Open Heart. 2021;8:e001685.

  21. Tanasa A, Burlacu A, Popa C, et al. A systematic review on the correlations between left atrial strain and cardiovascular outcomes in chronic kidney disease patients. Diagnostics (Basel). 2021;11:671.

  22. Nguyen J, Weber J, Hsu B, et al. Comparing left atrial indices by CMR in association with left ventricular diastolic dysfunction and adverse clinical outcomes. Sci Rep. 2021;11:21331.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Delgado V, Di Biase L, Leung M, et al. Structure and function of the left atrium and left atrial appendage: AF and stroke implications. J Am Coll Cardiol. 2017;70:3157–72.

    Article  PubMed  Google Scholar 

  24. Triposkiadis F, Xanthopoulos A, Butler J. Cardiovascular aging and heart failure: JACC review topic of the week. J Am Coll Cardiol. 2019;74:804–13.

    Article  PubMed  Google Scholar 

  25. Lin KJ, Cho SI, Tiwari N, et al. Impact of metabolic syndrome on the risk of atrial fibrillation recurrence after catheter ablation: systematic review and meta-analysis. J Interv Card Electrophysiol. 2014;39:211–23.

    Article  PubMed  Google Scholar 

  26. Balarini CM, Braga VA. Editorial: new translational insights on metabolic syndrome: obesity, hypertension. Diabetes and Beyond Front Physiol. 2016;7:229.

    PubMed  Google Scholar 

  27. Park HS, Sung JH, Ryu CS, et al. The synergistic effect of plasminogen activator inhibitor-1 (PAI-1) polymorphisms and metabolic syndrome on coronary artery disease in the Korean population. J Pers Med. 2020;10:229.

  28. Miller JT, O’Rourke RA, Crawford MH. Left atrial enlargement: an early sign of hypertensive heart disease. Am Heart J. 1988;116:1048–51.

    Article  CAS  PubMed  Google Scholar 

  29. Vidula MK, Chirinos JA. Left atrial coupling index and its prognostic value in heart failure with reduced ejection fraction. Circ Cardiovasc Imaging. 2021;14: e012221.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Chen YL, Chen YC, Chang YT, et al. GJA1 expression and left atrial remodeling in the incidence of atrial fibrillation in patients with obstructive sleep apnea syndrome. Biomedicines. 2021;9:1463.

  31. Bao L, Cheng L, Gao X, et al. Left atrial morpho-functional remodeling in atrial fibrillation assessed by three dimensional speckle tracking echocardiography and its value in atrial fibrillation screening. Cardiovasc Ultrasound. 2022;20:13.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the participants of the study.

Medical Writing, Editorial, and Other Assistance.

We would like to clarify that Heo Jeong-Heon, RT, provided technical assistance specifically in strain analysis for our study. His contributions were invaluable in ensuring the accuracy and reliability of the strain analysis data, which played a crucial role in our research findings. However, it is important to note that he did not participate in the writing or editing of the medical content of the paper, nor did he receive any funding for his contribution.

Authorship.

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Funding

This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIT) (No. 2021R1G1A11003683). The journal’s Rapid Service fee was provided by the NRF grant.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Hyun-Sun Kim, and Hyun-Jin Kim. The first draft of the manuscript was written by Hyun-Jin Kim and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Hyun-Jin Kim.

Ethics declarations

Conflict of Interest

Hyun-Jin Kim and Hyun-Sun Kim have nothing to disclose.

Ethical Approval

The study was approved by Hanyang University Guri Hospital’s institutional review board and conducted in accordance with the Declaration of Helsinki (No. GURI 2021–02–007). The requirement for written informed consent was waived by the institutional review boards.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 176 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, HJ., Kim, HS. Left Atrial Strain Insights in Atrial Fibrillation and the Interplay with Metabolic Syndrome. Adv Ther 41, 1685–1697 (2024). https://doi.org/10.1007/s12325-024-02815-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12325-024-02815-y

Keywords

Navigation